Table 1.
Regulation of aquaporin expression by traditional Chinese medicine in cardiovascular diseases.
| Type | Distribution | Function | Associated diseases | Traditional medicine | Aquaporin affected | Associated cardiovascular effects | Reference |
|---|---|---|---|---|---|---|---|
| AQP1 | Found in the kidneys, eyes, brain, lungs, etc. | Facilitates water transport across cell membranes, especially in renal tubules | Hypertension, kidney diseases, CHD, eye disorders | Yiqi Jianpi formula | AQP1↓ | Downregulates NF-κB, IL-6, and TNF-α and AQP1 expression in myocardial tissue, reducing inflammatory response and edema, and thereby improving coronary heart disease symptoms | (36) |
| Naoxintong capsules | AQP1↓ | Inhibits AQP1 expression, alleviates myocardial edema and cell apoptosis, and exerts cardioprotective effects | (37) | ||||
| XinLi formula | AQP1↓ | Alleviates myocardial fibrosis by inhibiting AGTR1/NLRP3 signaling, reducing plasma IL-1β, IL-18, IL-6, and TNF-α levels; mitigates myocardial edema by suppressing the interaction between AGTR1 and AQP1 | (5) | ||||
| AQP2 | Primarily in renal collecting ducts | Regulates water reabsorption, crucial for maintaining water balance | Kidney diseases, heart failure, hypertension, hyponatremia | Bushen Huoxue recipe | AQP2↓ | Decreases serum BNP in CHF rats and downregulates AQP2 in renal tissue, thereby improving cardiac function | (38) |
| Descurainiae sophia | AQP2↓ | Targets the RAAS and AVP systems to reduce AQP2 expression in renal tissue, increases urine output, and thus improves heart failure | (39) | ||||
| Wenyang Xiaoying | AQP2↑ | Reduces serum BNP levels in a CHF rat model and upregulates renal AQP2 | (40) | ||||
| AQP3 | Found in the kidneys, skin, gastrointestinal tract, and lungs | Participates in water reabsorption and glycerol transport | Xerosis, skin hydration, cardiac toxic injury, and kidney diseases | Ganoderma lucidum | AQP3↓ | Downregulates AQP3, AQP4, and AQP7 levels, improving myocardial cell injury | (41) |
| AQP4 | Found in the brain, spinal cord, and eyes | Regulates cerebrospinal fluid and water balance in the brain | Brain edema, chronic pulmonary heart disease, multiple sclerosis | Jianxin Pinglv pills | AQP4↑ | Reduces the incidence and mortality of reperfusion arrhythmias and alleviates ischemic myocardial edema injury | (42) |
| Jian Xin soups | AQP4↑ | Inhibits the inflammatory response, improving cardiac function and blood oxygenation | (43) | ||||
| Tongxinluo capsules | AQP4↓ | Inhibits AQP1, AQP4, AQP8, and AQP9 expression, reducing myocardial edema and ameliorating myocardial cell injury | (44) | ||||
| AQP7 | Found in adipose tissue, liver, and kidneys | Primarily responsible for glycerol and water transport | Diabetes, obesity, cardiac toxic injury | Yiqi Wenyang Zhushui soups | AQP7↓ | Improves heart failure status, enhances ATP levels in failing hearts, and downregulates AQP1, AQP4, and AQP7 | (45) |
| Xinshuitong capsule | Suppresses AQP1, AQP4, and AQP7 expression, alleviating myocardial edema and cardiac remodeling, thereby mitigating the cardiotoxicity of antineoplastic agents | (46) | |||||
| AQP8 | Found in the liver, kidneys, and pancreas | Facilitates water and glycerol transport | Liver diseases, myocardial infarction, and pancreatic disorders | Tongxinluo capsule | AQP8↓ | Inhibits AQP1, AQP4, AQP8, and AQP9 expression, reducing myocardial edema and alleviating myocardial cell injury | (44) |
| AQP9 | Found in the liver and white blood cells | Regulates water and glycerol transport | Liver diseases, myocardial infarction, and immune system disorders | Tongxinluo capsules | AQP9↓ | Inhibits AQP1, AQP4, AQP8, and AQP9 expression, reducing myocardial edema and alleviating myocardial cell injury | (44) |
NF-κB, nuclear factor kappa B; IL-6, interleukin 6; TNF-α, tumor necrosis factor alpha; CHF, chronic heart failure; CHD, coronary heart disease.